These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 30485582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    McAleese KE, Miah M, Graham S, Hadfield GM, Walker L, Johnson M, Colloby SJ, Thomas AJ, DeCarli C, Koss D, Attems J.
    Acta Neuropathol; 2021 Dec; 142(6):937-950. PubMed ID: 34608542
    [Abstract] [Full Text] [Related]

  • 3. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.
    McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J.
    Acta Neuropathol; 2017 Sep; 134(3):459-473. PubMed ID: 28638989
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.
    Miners JS, Schulz I, Love S.
    J Cereb Blood Flow Metab; 2018 Jan; 38(1):103-115. PubMed ID: 28151041
    [Abstract] [Full Text] [Related]

  • 8. Past antihypertensive medication use is associated with lower levels of small vessel disease and lower Aβ plaque stage in the brains of older individuals.
    Affleck AJ, Sachdev PS, Halliday GM.
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12922. PubMed ID: 37431095
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. White matter hyperintensities: relationship to amyloid and tau burden.
    Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, Gunter JL, Senjem ML, Przybelski SA, Lesnick T, Ward C, Mielke MM, Lowe VJ, Petersen RC, Kremers WK, Kantarci K, Jack CR, Vemuri P.
    Brain; 2019 Aug 01; 142(8):2483-2491. PubMed ID: 31199475
    [Abstract] [Full Text] [Related]

  • 11. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.
    Magaki S, Tang Z, Tung S, Williams CK, Lo D, Yong WH, Khanlou N, Vinters HV.
    Neurobiol Aging; 2018 Oct 01; 70():70-77. PubMed ID: 30007166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M, Wanner D, Nitsch RM.
    Acta Neuropathol; 2016 May 01; 131(5):737-52. PubMed ID: 26988843
    [Abstract] [Full Text] [Related]

  • 14. Vascular pathology in the aged human brain.
    Grinberg LT, Thal DR.
    Acta Neuropathol; 2010 Mar 01; 119(3):277-90. PubMed ID: 20155424
    [Abstract] [Full Text] [Related]

  • 15. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P, Tchounguen J, Pettigrew C, Lim C, Lin Z, Lu H, Moghekar A, Albert M, Soldan A, BIOCARD Research Team.
    J Alzheimers Dis; 2023 Mar 01; 92(1):323-339. PubMed ID: 36744337
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer's and small vessel disease pathologies.
    Waller R, Narramore R, Simpson JE, Heath PR, Verma N, Tinsley M, Barnes JR, Haris HT, Henderson FE, Matthews FE, Richardson CD, Brayne C, Ince PG, Kalaria RN, Wharton SB, CFAS.
    Brain Pathol; 2021 May 01; 31(3):e12928. PubMed ID: 33336479
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C, Walker L, Rauchmann BS, Perneczky R.
    Neuropathol Appl Neurobiol; 2022 Apr 01; 48(3):e12782. PubMed ID: 34823269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.